Literature DB >> 28462232

Practical and theoretical implications of weight gain in advanced non-small cell lung cancer patients.

Philip Bonomi1, Marta Batus1, Mary Jo Fidler1, Jeffrey A Borgia2.   

Abstract

Entities:  

Year:  2017        PMID： 28462232      PMCID： PMC5395479          DOI： 10.21037/atm.2017.03.20

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.

Authors:  Benjamin T Gielda; Par Mehta; Atif Khan; James C Marsh; Thomas W Zusag; William H Warren; Mary Jo Fidler; Ross A Abrams; Philip Bonomi; Michael Liptay; L Penfield Faber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-06       Impact factor: 7.038

2.  Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study.

Authors:  Sami Antoun; Laura Birdsell; Michael B Sawyer; Peter Venner; Bernard Escudier; Vickie E Baracos
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

3.  Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.

Authors:  Lisa Martin; Laura Birdsell; Neil Macdonald; Tony Reiman; M Thomas Clandinin; Linda J McCargar; Rachel Murphy; Sunita Ghosh; Michael B Sawyer; Vickie E Baracos
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

4.  Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.

Authors:  Carla M M Prado; Vickie E Baracos; Linda J McCargar; Tony Reiman; Marina Mourtzakis; Katia Tonkin; John R Mackey; Sheryl Koski; Edith Pituskin; Michael B Sawyer
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

Review 5.  Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.

Authors:  Yuji Miyamoto; Diana L Hanna; Wu Zhang; Hideo Baba; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2016-06-23       Impact factor: 12.531

6.  Weight gain as a surrogate marker of longer survival in advanced non-small cell lung cancer patients.

Authors:  Erkan Topkan
Journal:  Ann Transl Med       Date:  2016-10

Review 7.  Understanding the mechanisms and treatment options in cancer cachexia.

Authors:  Kenneth Fearon; Jann Arends; Vickie Baracos
Journal:  Nat Rev Clin Oncol       Date:  2012-12-04       Impact factor: 66.675

Review 8.  Cancer metabolism: a therapeutic perspective.

Authors:  Ubaldo E Martinez-Outschoorn; Maria Peiris-Pagés; Richard G Pestell; Federica Sotgia; Michael P Lisanti
Journal:  Nat Rev Clin Oncol       Date:  2016-05-04       Impact factor: 66.675

9.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

10.  Impact of weight change during the course of concurrent chemoradiation therapy on outcomes in stage IIIB non-small cell lung cancer patients: retrospective analysis of 425 patients.

Authors:  Erkan Topkan; Cem Parlak; Ugur Selek
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-09-10       Impact factor: 7.038
View more
  2 in total

1.  Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer Survival.

Authors:  Qianyu Yuan; Mulong Du; Elizabeth Loehrer; Bruce E Johnson; Justin F Gainor; Michael Lanuti; Yi Li; David C Christiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-02       Impact factor: 4.090

2.  Propranolol Promotes Glucose Dependence and Synergizes with Dichloroacetate for Anti-Cancer Activity in HNSCC.

Authors:  Christopher T Lucido; W Keith Miskimins; Paola D Vermeer
Journal:  Cancers (Basel)       Date:  2018-11-30       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.